×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
Faculty of Healt... [1]
THE STATE KEY LA... [1]
Authors
CHEN XIN [1]
LU JINJIAN [1]
CHEN XIUPING [1]
LIN LIGEN [1]
Document Type
Journal article [3]
Date Issued
2021 [1]
2020 [1]
2011 [1]
Language
英語English [2]
Source Publication
Acta Pharmacolog... [1]
Cancer Biology a... [1]
Toxicology and A... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
Journal article
Li, Ping, Chen, Fengyang, Zheng, Jingbin, Yang, Yang, Li, Yuan, Wang, Yifei, Chen, Xin*. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas[J]. Cancer Biology and Medicine, 2021, 18(4), 1010-1020.
Authors:
Li, Ping
;
Chen, Fengyang
;
Zheng, Jingbin
;
Yang, Yang
;
Li, Yuan
; et al.
Favorite
|
TC[WOS]:
8
TC[Scopus]:
7
IF:
5.6
/
5.9
|
Submit date:2021/12/08
Bleomycin
Cyclophosphamide
Tnfr2
Tregs
Tumor Necrosis Factor
Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway
Journal article
Li,Ao, Xiao,Xiao, Feng,Zhe Ling, Chen,Xiuping, Liu,Li Juan, Lin,Li Gen, Lu,Jin Jian, Zhang,Le Le. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway[J]. Toxicology and Applied Pharmacology, 2020, 389, 114882.
Authors:
Li,Ao
;
Xiao,Xiao
;
Feng,Zhe Ling
;
Chen,Xiuping
;
Liu,Li Juan
; et al.
Favorite
|
TC[WOS]:
19
TC[Scopus]:
20
IF:
3.3
/
3.6
|
Submit date:2021/03/01
Bleomycin
Fibrotic Process
Nagilactone d
Pulmonary Fibrosis
Tgf-β1
Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury
Journal article
He M., Cheng N., Gao W.-W., Zhang M., Zhang Y.-Y., Ye R.D., Wang M.-W.. Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury[J]. Acta Pharmacologica Sinica, 2011, 32(5), 601-610.
Authors:
He M.
;
Cheng N.
;
Gao W.-W.
;
Zhang M.
;
Zhang Y.-Y.
; et al.
Favorite
|
TC[WOS]:
32
TC[Scopus]:
33
|
Submit date:2018/11/07
Anti-inflammation
Bleomycin
Cytokines
Formyl Peptide Receptor
Lung Injury
Quin-c1